Lin Xiaochen, Tsai Ming-Han, Shumilov Anatoliy, Poirey Remy, Bannert Helmut, Middeldorp Jaap M, Feederle Regina, Delecluse Henri-Jacques
Division of pathogenesis of Virus Associated Tumors, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
Inserm unit U1074, DKFZ, Heidelberg, Germany.
PLoS Pathog. 2015 Dec 22;11(12):e1005344. doi: 10.1371/journal.ppat.1005344. eCollection 2015 Dec.
The Epstein-Barr virus (EBV) is a B lymphotropic virus that infects the majority of the human population. All EBV strains transform B lymphocytes, but some strains, such as M81, also induce spontaneous virus replication. EBV encodes 22 microRNAs (miRNAs) that form a cluster within the BART region of the virus and have been previously been found to stimulate tumor cell growth. Here we describe their functions in B cells infected by M81. We found that the BART miRNAs are downregulated in replicating cells, and that exposure of B cells in vitro or in vivo in humanized mice to a BART miRNA knockout virus resulted in an increased proportion of spontaneously replicating cells, relative to wild type virus. The BART miRNAs subcluster 1, and to a lesser extent subcluster 2, prevented expression of BZLF1, the key protein for initiation of lytic replication. Thus, multiple BART miRNAs cooperate to repress lytic replication. The BART miRNAs also downregulated pro- and anti-apoptotic mediators such as caspase 3 and LMP1, and their deletion did not sensitize B-cells to apoptosis. To the contrary, the majority of humanized mice infected with the BART miRNA knockout mutant developed tumors more rapidly, probably due to enhanced LMP1 expression, although deletion of the BART miRNAs did not modify the virus transforming abilities in vitro. This ability to slow cell growth could be confirmed in non-humanized immunocompromized mice. Injection of resting B cells exposed to a virus that lacks the BART miRNAs resulted in accelerated tumor growth, relative to wild type controls. Therefore, we found that the M81 BART miRNAs do not enhance B-cell tumorigenesis but rather repress it. The repressive effects of the BART miRNAs on potentially pathogenic viral functions in infected B cells are likely to facilitate long-term persistence of the virus in the infected host.
爱泼斯坦-巴尔病毒(EBV)是一种嗜B淋巴细胞病毒,可感染大多数人群。所有EBV毒株均可转化B淋巴细胞,但有些毒株,如M81,还会诱导病毒自发复制。EBV编码22种微小RNA(miRNA),这些miRNA在病毒的BART区域内形成一个簇,此前已发现它们可刺激肿瘤细胞生长。在此,我们描述了它们在受M81感染的B细胞中的功能。我们发现,BART miRNA在复制细胞中表达下调,并且在体外或人源化小鼠体内将B细胞暴露于缺失BART miRNA的病毒中,相对于野生型病毒,自发复制细胞的比例增加。BART miRNA亚簇1,以及程度较轻的亚簇2,可阻止BZLF1的表达,BZLF1是裂解复制起始的关键蛋白。因此,多种BART miRNA协同作用以抑制裂解复制。BART miRNA还下调了促凋亡和抗凋亡介质,如半胱天冬酶3和潜伏膜蛋白1(LMP1),它们的缺失并未使B细胞对凋亡敏感。相反,大多数感染了缺失BART miRNA突变体的人源化小鼠肿瘤生长更快,这可能是由于LMP1表达增强,尽管缺失BART miRNA并未改变病毒在体外的转化能力。这种减缓细胞生长的能力在非人源化免疫受损小鼠中也得到了证实。相对于野生型对照,注射暴露于缺乏BART miRNA病毒的静止B细胞会导致肿瘤生长加速。因此,我们发现M81 BART miRNA不会增强B细胞肿瘤发生,而是会抑制它。BART miRNA对受感染B细胞中潜在致病病毒功能的抑制作用可能有助于病毒在受感染宿主中长期持续存在。